You are viewing: Canada Elastomeric Infusion Pumps Market analysis

The Canada Elastomeric Infusion Pumps Market was valued at $21.1 Million in 2025 and projected to reach to $24.2 Million by 2030, representing a compound annual growth rate of 2.8%. Canada's elastomeric infusion pumps market demonstrates stable growth driven by an aging demographic, increased prevalence of chronic diseases, and healthcare providers' preference for cost-effective portable delivery systems.

Canada Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Elastomeric Infusion Pumps Market Trends and Insights

  • This moderate growth trajectory reflects Canada's mature healthcare infrastructure and steady demand for portable drug delivery solutions across oncology, pain management, and antibiotic therapies.
  • Canada's regulatory environment and healthcare reimbursement policies continue to support adoption of elastomeric infusion pump technologies among hospitals and home care providers. The Canadian market benefits from an aging population and increasing prevalence of chronic diseases requiring continuous medication delivery.
  • Canada's emphasis on cost-effective healthcare solutions and patient-centric care models drives preference for elastomeric pumps over electronic alternatives in select clinical settings.
  • Between 2025 and 2030, Canada is expected to see incremental market expansion driven by improved product awareness, clinical evidence accumulation, and integration into Canada's provincial healthcare systems..

Key Market Statistics

  • CAGR (2025-2030) 2.8% CAGR
  • Market Size, 2025 ~USD 21.1 Million
  • Forecast, 2030 ~USD 24.2 Million
  • Country Canada

Canada Elastomeric Infusion Pumps Market Overview

Market Valuation :

Canada's elastomeric infusion pumps market is valued at $21.1 million in 2025, with projections reaching $24.2 million by 2030, representing steady growth in the medical device sector.

Growth Rate :

The Canadian market expands at a CAGR of 2.8% through 2030, reflecting a mature healthcare system with consistent demand for portable drug delivery solutions.

Clinical Applications :

Primary demand drivers in Canada include oncology treatments, chronic pain management, and antibiotic therapies, supported by Canada's universal healthcare coverage and aging population.

Regulatory Environment :

Health Canada's stringent medical device approval processes and emphasis on patient safety ensure high-quality elastomeric pump adoption across Canadian healthcare institutions.

Canada Elastomeric Infusion Pumps Market Dynamics

  • The mature Canadian healthcare infrastructure supports consistent adoption across hospitals, clinics, and home care settings.
  • Growth is tempered by market saturation in urban centers and competitive pricing pressures from established manufacturers.
  • Provincial healthcare budgets and reimbursement policies significantly influence purchasing decisions across Canada's decentralized healthcare system.
  • Innovation in pump design and connectivity features will be critical for capturing incremental market share among Canadian healthcare providers seeking enhanced patient outcomes and operational efficiency..

Related Ecosystem

Key Takeaways

  • Canada's elastomeric infusion pumps market is valued at $21.1 million in 2025 with a projected value of $24.2 million by 2030.
  • Canada experiences a 2.8% CAGR, reflecting steady but moderate growth compared to global expansion rates.
  • Canada's aging demographic and chronic disease prevalence support sustained demand for portable infusion delivery systems.
  • Canada's healthcare cost-containment focus and provincial reimbursement policies favor elastomeric pump adoption in home and hospital settings.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

Canada Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030

Segment20232024202520262027202820292030CAGR (%)
AMBULATORY SURGICAL CENTERS (ASCS)5.445.545.715.886.056.246.426.623
HOMECARE SETTINGS4.234.314.444.584.724.875.025.183.1
HOSPITALS9.719.8910.1510.4210.6910.9711.2611.552.6
OTHER END-USE INDUSTRIES0.770.780.80.810.830.850.870.882.1
TOTAL20.1620.5221.121.6922.322.9223.5624.222.8

Target Audience

  • Medical Device Manufacturers : Manufacturers need Canada-specific market data to develop localized go-to-market strategies, understand competitive positioning, and identify opportunities for product launches or market expansion.
  • Healthcare Procurement Officers : Hospital and clinic procurement teams require market insights to evaluate supplier options, negotiate pricing, and make informed purchasing decisions aligned with provincial healthcare budgets.
  • Investment & Private Equity Firms : Investors evaluating Canadian healthcare companies need market sizing and growth forecasts to assess investment returns, identify acquisition targets, and understand sector dynamics.
  • Regulatory & Compliance Consultants : Consultants advising medical device companies on Canadian market entry need detailed regulatory landscape and reimbursement information to guide compliance strategies and market positioning.
  • Healthcare System Administrators : Provincial health authorities and hospital networks require market intelligence to plan capital expenditures, evaluate technology adoption, and optimize drug delivery infrastructure investments.

Key Companies in the Canada Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Market-Specific Sizing : Access precise valuation data for Canada's elastomeric infusion pumps market with 2025-2030 forecasts, enabling accurate budget allocation and revenue projections for Canadian operations.
  • Regulatory & Reimbursement Insights : Understand Health Canada approval pathways, provincial reimbursement policies, and healthcare funding mechanisms that directly impact market entry and pricing strategies in Canada.
  • Clinical Application Trends : Identify high-demand therapeutic areas in Canada including oncology, pain management, and antibiotic delivery, with insights into Canadian hospital procurement patterns and clinical preferences.
  • Competitive Landscape Analysis : Benchmark against established and emerging competitors in the Canadian market, understanding market share distribution and differentiation opportunities specific to Canadian healthcare providers.
  • Growth Opportunity Assessment : Evaluate the 2.8% CAGR trajectory against global benchmarks (5.3%), identifying underserved segments and expansion opportunities within Canada's provincial healthcare systems.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in Canada?

Canada's elastomeric infusion pumps market is valued at $21.1 million in 2025 according to verified market data.

What is the projected market size for elastomeric infusion pumps in Canada by 2030?

Canada's elastomeric infusion pumps market is forecast to reach $24.2 million by 2030, representing growth from the 2025 baseline.

What is the CAGR for Canada's elastomeric infusion pumps market?

Canada's elastomeric infusion pumps market is expected to grow at a compound annual growth rate of 2.8% between 2025 and 2030.

What factors drive elastomeric infusion pump demand in Canada?

Canada's demand is driven by an aging population, increasing chronic disease prevalence, healthcare cost-containment priorities, and provincial reimbursement support for portable drug delivery solutions.

How does Canada's market growth compare to global trends?

Canada's 2.8% CAGR is lower than the global 5.3% CAGR, reflecting Canada's mature healthcare market and more conservative adoption patterns relative to emerging regions.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status